Clinical Trial Detail

NCT ID NCT04143789
Title Evaluation of AP-002 in Patients With Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Altum Pharmaceuticals INC
Indications

Advanced Solid Tumor

prostate cancer

breast cancer

lung non-small cell carcinoma

Therapies

AP-002

Age Groups: adult

No variant requirements are available.